Healthcare provider profile · identity verified

Mohammad Al Darawsha, MD

Internal Medicine · GEORGETOWN, TX · NPI 1417443243

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	326	96
Levothyroxine Sodium	Levothyroxine Sodium	279	63
Pantoprazole Sodium	Pantoprazole Sodium	274	72
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	266	94
Omeprazole	Omeprazole	247	68
Lisinopril	Lisinopril	245	75
Gabapentin	Gabapentin	241	61
Amlodipine Besylate	Amlodipine Besylate	226	61
Rosuvastatin Calcium	Rosuvastatin Calcium	218	58
Losartan Potassium	Losartan Potassium	210	48
Furosemide	Furosemide	208	62
Carvedilol	Carvedilol	206	42
Metformin Hcl	Metformin Hcl	185	55
Tamsulosin Hcl	Tamsulosin Hcl	183	52
Celecoxib	Celecoxib	172	40
Simvastatin	Simvastatin	160	49
Albuterol Sulfate Hfa	Albuterol Sulfate	146	47
Potassium Chloride	Potassium Chloride	138	40
Montelukast Sodium	Montelukast Sodium	133	39
Alprazolam	Alprazolam	131	43
Metoprolol Tartrate	Metoprolol Tartrate	125	36
Duloxetine Hcl	Duloxetine Hcl	114	25
Famotidine	Famotidine	96	15
Glipizide	Glipizide	95	21
Terazosin Hcl	Terazosin Hcl	93	20
Hydrochlorothiazide	Hydrochlorothiazide	89	21
Metoprolol Succinate	Metoprolol Succinate	89	26
Azithromycin	Azithromycin	88	73
Trazodone Hcl	Trazodone Hcl	87	23
Clopidogrel	Clopidogrel Bisulfate	83	27
Prednisone	Prednisone	79	47
Tradjenta	Linagliptin	79	17
Tramadol Hcl	Tramadol Hcl	70	36
Citalopram Hbr	Citalopram Hydrobromide	69	17
Levetiracetam	Levetiracetam	68	suppressed
Pregabalin	Pregabalin	67	18
Methylprednisolone	Methylprednisolone	64	60
Eliquis	Apixaban	62	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	62	26
Venlafaxine Hcl Er	Venlafaxine Hcl	62	suppressed
Fluticasone Propionate	Fluticasone Propionate	60	23
Quetiapine Fumarate	Quetiapine Fumarate	60	17
Ropinirole Hcl	Ropinirole Hcl	60	14
Oxycodone Hcl	Oxycodone Hcl	58	19
Baclofen	Baclofen	56	19
Cephalexin	Cephalexin	54	46
Zolpidem Tartrate	Zolpidem Tartrate	52	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	13
Hydroxyzine Hcl	Hydroxyzine Hcl	49	11
Olanzapine	Olanzapine	49	suppressed
Allopurinol	Allopurinol	48	19
Ezetimibe	Ezetimibe	47	12
Buspirone Hcl	Buspirone Hcl	46	11
Ozempic	Semaglutide	46	suppressed
Spironolactone	Spironolactone	42	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	41	17
Metformin Hcl Er	Metformin Hcl	41	12
Hydralazine Hcl	Hydralazine Hcl	40	13
Esomeprazole Magnesium	Esomeprazole Magnesium	39	suppressed
Sertraline Hcl	Sertraline Hcl	39	11
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	16
Torsemide	Torsemide	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	11
Nifedipine Er	Nifedipine	35	12
Triamcinolone Acetonide	Triamcinolone Acetonide	35	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	29
Donepezil Hcl	Donepezil Hcl	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Clonazepam	Clonazepam	32	12
Tizanidine Hcl	Tizanidine Hcl	32	15
Valacyclovir	Valacyclovir Hcl	32	suppressed
Finasteride	Finasteride	31	11
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Telmisartan	Telmisartan	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	13
Lorazepam	Lorazepam	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	24
Lactulose	Lactulose	26	11
Mirtazapine	Mirtazapine	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	15
Memantine Hcl	Memantine Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Bupropion Hcl	Bupropion Hcl	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Metolazone	Metolazone	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Levofloxacin	Levofloxacin	17	15
Nitroglycerin	Nitroglycerin	17	12
Sotalol	Sotalol Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Calcitriol	Calcitriol	16	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Clonidine Hcl	Clonidine Hcl	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Valsartan	Valsartan	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Atenolol	Atenolol	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Topiramate	Topiramate	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Bupropion Xl	Bupropion Hcl	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	13
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Meloxicam	Meloxicam	14	11
Metronidazole	Metronidazole	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Nystatin	Nystatin	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Linzess	Linaclotide	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Procrit	Epoetin Alfa	12	suppressed
Restasis	Cyclosporine	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error